Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Cooperativity of adaptive and innate immunity: implications for cancer therapy.

Shanker A, Marincola FM.

Cancer Immunol Immunother. 2011 Aug;60(8):1061-74. doi: 10.1007/s00262-011-1053-z. Epub 2011 Jun 9. Review.

2.

Innate immune mediators in cancer: between defense and resistance.

Berraondo P, Minute L, Ajona D, Corrales L, Melero I, Pio R.

Immunol Rev. 2016 Nov;274(1):290-306. doi: 10.1111/imr.12464. Review.

PMID:
27782320
3.

Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment.

Croci DO, Zacarías Fluck MF, Rico MJ, Matar P, Rabinovich GA, Scharovsky OG.

Cancer Immunol Immunother. 2007 Nov;56(11):1687-700. Epub 2007 Jun 15. Review.

PMID:
17571260
4.

Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells.

Zwirner NW, Croci DO, Domaica CI, Rabinovich GA.

Curr Pharm Des. 2010 Jan;16(3):255-67. Review.

PMID:
20109135
5.

Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways.

Li K, Qu S, Chen X, Wu Q, Shi M.

Int J Mol Sci. 2017 Feb 14;18(2). pii: E404. doi: 10.3390/ijms18020404. Review.

6.

Manipulation of Innate and Adaptive Immunity through Cancer Vaccines.

Sayour EJ, Mitchell DA.

J Immunol Res. 2017;2017:3145742. doi: 10.1155/2017/3145742. Epub 2017 Feb 6. Review.

7.

Enhancing Cancer Immunotherapy Via Activation of Innate Immunity.

Goldberg JL, Sondel PM.

Semin Oncol. 2015 Aug;42(4):562-72. doi: 10.1053/j.seminoncol.2015.05.012. Epub 2015 Jun 3. Review.

8.

TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy.

Akalu YT, Rothlin CV, Ghosh S.

Immunol Rev. 2017 Mar;276(1):165-177. doi: 10.1111/imr.12522. Review.

PMID:
28258690
9.

Bidirectional interactions of NK cells and dendritic cells in immunotherapy: current and future perspective.

Mahmood S, Upreti D, Sow I, Amari A, Nandagopal S, Kung SK.

Immunotherapy. 2015;7(3):301-8. doi: 10.2217/imt.14.122. Review.

PMID:
25804481
10.

Chemokine-chemokine receptors in cancer immunotherapy.

Stewart TJ, Smyth MJ.

Immunotherapy. 2009 Jan;1(1):109-27. doi: 10.2217/1750743X.1.1.109. Review.

PMID:
20635978
11.

The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.

Wallace ME, Smyth MJ.

Springer Semin Immunopathol. 2005 Jun;27(1):49-64. Epub 2005 Feb 24. Review.

PMID:
15729567
12.

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Schreiber RD, Old LJ, Smyth MJ.

Science. 2011 Mar 25;331(6024):1565-70. doi: 10.1126/science.1203486. Review.

PMID:
21436444
13.

Natural innate and adaptive immunity to cancer.

Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ.

Annu Rev Immunol. 2011;29:235-71. doi: 10.1146/annurev-immunol-031210-101324. Review.

PMID:
21219185
14.

Immunotherapy of cancer: reprogramming tumor-immune crosstalk.

Payne KK, Toor AA, Wang XY, Manjili MH.

Clin Dev Immunol. 2012;2012:760965. doi: 10.1155/2012/760965. Epub 2012 Oct 11. Review.

15.

Cancer and innate immune system interactions: translational potentials for cancer immunotherapy.

Liu Y, Zeng G.

J Immunother. 2012 May;35(4):299-308. doi: 10.1097/CJI.0b013e3182518e83. Review.

16.

Harnessing the immune system to treat cancer.

Bhardwaj N.

J Clin Invest. 2007 May;117(5):1130-6. Review.

17.

Systems biology applied to vaccine and immunotherapy development.

Buonaguro L, Wang E, Tornesello ML, Buonaguro FM, Marincola FM.

BMC Syst Biol. 2011 Sep 20;5:146. doi: 10.1186/1752-0509-5-146. Review.

18.

Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines.

Butt AQ, Mills KH.

Oncogene. 2014 Sep 18;33(38):4623-31. doi: 10.1038/onc.2013.432. Epub 2013 Oct 21. Review.

PMID:
24141774
19.

The role of microglia in central nervous system immunity and glioma immunology.

Yang I, Han SJ, Kaur G, Crane C, Parsa AT.

J Clin Neurosci. 2010 Jan;17(1):6-10. doi: 10.1016/j.jocn.2009.05.006. Epub 2009 Nov 18. Review.

20.

IL-27 in tumor immunity and immunotherapy.

Murugaiyan G, Saha B.

Trends Mol Med. 2013 Feb;19(2):108-16. doi: 10.1016/j.molmed.2012.12.002. Epub 2013 Jan 7. Review.

PMID:
23306374

Supplemental Content

Support Center